The ABPI is making a temporary change to the way Disclosure UK data is published to minimise any pressure on the NHS during the COVID-19 pandemic.
Following the announcement to ease lockdown measures in England, the UK government has published guidance to support the safe return to work for people in various sectors.
The NIHR has set out a framework for the resumption of health research that was paused as a result of the COVID-19 pandemic.
The Chief Executive of the ABPI has today told the International Trade Committee that the coronavirus pandemic shows why resilient, global supply of medicines is so important.
The UK Government has put out a ‘call to arms’ to the life sciences industry to help them rapidly develop coronavirus testing as part of the Health Secretary’s pledge to carry out 100,000 tests a day by the end of April.
NHS England, the Association of the British Pharmaceutical Industry (ABPI) and the AHSN Network have joined forces to launch an ambitious new programme, connecting digital health innovators with pharmaceutical companies to explore new innovations that could help people living with diabetes.
Four trade bodies representing the life sciences sector have released a joint statement on testing kits for COVID-19.
The Department of Health and Social Care has published the latest Voluntary Scheme sales data for Q4 2019 which brings the total branded growth rate for 2019 versus 2018 to 1.6%.
As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to this outbreak.
The Chancellor Rishi Sunak has delivered his first Budget, and the first for the Government following last year's General Election.